《新股表现》医渡科技(02158.HK)暗盘高开90%报50元
根据辉立交易平台显示,明天挂牌的医渡科技(02158.HK)暗盘高开90%报50元获承接,暂时最高见63.3元,现造62.3元,较上市价26.3元,高1.37倍,成交108万股。
医渡是一家提供基於大数据及人工智能技术解决方案的医疗技术公司。是次在港上市共发售1.5645亿股,并已引入包括OrbiMed Funds、加拿大退休金计划投资委员会及文莱投资局旗下Yaqut Sdn Bhd、腾讯(00700.HK)附属Tencent Mobility、嘉里控股旗下Velmar、Matthews Funds、3W Fund Management及中国东方等八名基石投资者,合期认购6,188.62万股;10%公开发售获近1,633倍超购,启动回拨机制後占比增至50%,认购一手中签率20%;股份以招股范围(23.5-26.3元)上限定价,料集资净额约39.02亿元,主要用作加强数据处理技术和机器学习算法等核心能力;为业务运营提供资金及进一步进行业务扩张,包括为现有及新市场开发新的应用和解决方案;通过战略合夥、投资及收购来进一步丰富公司的生态系统。上市联席保荐人分别为高盛及中金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.